Partial deletion of the long arm of chromosome 19 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:262155
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial deletion of the long arm of chromosome 19 syndrome (also referred to as 19q partial monosomy or 19q deletion syndrome) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 19. The clinical presentation varies considerably depending on the size and precise location of the deleted segment. Because chromosome 19 is gene-dense, even relatively small deletions can affect multiple body systems. Commonly reported features include intellectual disability of variable severity, developmental delay (particularly speech and motor milestones), growth retardation, and a range of dysmorphic facial features such as a broad nasal bridge, micrognathia, low-set ears, and hypertelorism. Additional findings may include hypotonia, feeding difficulties in infancy, cardiac malformations, skeletal anomalies, and behavioral abnormalities. Some patients also present with microcephaly and seizures. The phenotype is highly variable and correlates with the specific chromosomal breakpoints involved. There is no curative treatment for this condition. Management is supportive and multidisciplinary, focusing on early intervention programs including speech therapy, physical therapy, and occupational therapy. Cardiac, neurological, and orthopedic complications are addressed as needed. Regular developmental assessments and individualized educational plans are important components of long-term care. Genetic counseling is recommended for affected families to assess recurrence risk, which depends on whether the deletion arose de novo or was inherited from a parent carrying a balanced chromosomal rearrangement.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial deletion of the long arm of chromosome 19 syndrome.

View clinical trials →

No actively recruiting trials found for Partial deletion of the long arm of chromosome 19 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial deletion of the long arm of chromosome 19 syndrome community →

No specialists are currently listed for Partial deletion of the long arm of chromosome 19 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial deletion of the long arm of chromosome 19 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial deletion of the long arm of chromosome 19 syndromeForum →

No community posts yet. Be the first to share your experience with Partial deletion of the long arm of chromosome 19 syndrome.

Start the conversation →

Latest news about Partial deletion of the long arm of chromosome 19 syndrome

No recent news articles for Partial deletion of the long arm of chromosome 19 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial deletion of the long arm of chromosome 19 syndrome

What is Partial deletion of the long arm of chromosome 19 syndrome?

Partial deletion of the long arm of chromosome 19 syndrome (also referred to as 19q partial monosomy or 19q deletion syndrome) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 19. The clinical presentation varies considerably depending on the size and precise location of the deleted segment. Because chromosome 19 is gene-dense, even relatively small deletions can affect multiple body systems. Commonly reported features include intellectual disability of variable severity, developmental delay (particularly speech and mot

At what age does Partial deletion of the long arm of chromosome 19 syndrome typically begin?

Typical onset of Partial deletion of the long arm of chromosome 19 syndrome is neonatal. Age of onset can vary across affected individuals.